Assessing sleep disturbances in Turkish patients with multiple sclerosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the validity and reliability of the Turkish version of the General Sleep Disturbance Scale (GSDS-T) specifically for patients diagnosed with multiple sclerosis (MS). It will involve 126 participants who have been living with MS for at least two years and will assess various aspects of sleep quality and disturbances. The study will utilize the Pittsburgh Sleep Quality Index (PSQI) as a benchmark for evaluating the GSDS-T, with scales being repeated after 15 days to measure test-retest reliability. The findings could provide valuable insights into sleep issues faced by MS patients in Turkey.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Individuals over the age of 18 who have been diagnosed with Multiple Sclerosis for at least two years,
* Those with an EDSS score \>2.
* Those without symptoms of insomnia according to the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) diagnostic criteria
* Individuals whose native language is Turkish and who have the ability to speak and understand.

Exclusion Criteria:

* Those with severe spasticity,
* Those with vision and hearing problems,
* Those with a known mental illness (major depression, schizophrenia, psychosis, etc.),
* Those in an acute relapse phase,
* Those using dietary supplements,
* Those using tranquilizers or immunosuppressants.

Where it's running

• Bağcılar Training and Research Hospital
  Bağcılar, Istanbul, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Emel Mete
• Email: meteemel53@gmail.com
• Phone: +905376096265

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Improving Sleep for Older Adults in the Emergency Department

  This project tests whether wearing a Fitbit overnight can help understand and improve sleep for adults 70 and older in the emergency department who are likely to be admitted.

  Recruiting at 2 sites University Health Network, Toronto · Toronto, Ontario and 1 other locations · NCT07928141

• Treadmill-based virtual reality walking training for MS patients

  This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.

  Recruiting Shepherd Center, Atlanta GA · Atlanta, Georgia · NCT07927439

• Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS

  This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.

  Recruiting Cairo University · Giza, Giza Governorate · NCT07918339

• REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care

  This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.

  Recruiting Imperial College London · London and 2 other locations · NCT07899502

• Tolebrutinib in real-world MS care for patients treated by clinicians

  This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.

  Recruiting Sanofi · Marina, Abu Dhabi Emirate · NCT07898371

• Pilates via live video vs. prerecorded videos for people with multiple sclerosis

  This study tests whether live, coach-led Pilates sessions through video calls are more beneficial than prerecorded Pilates videos for adults with MS.

  Recruiting Yuzuncu Yil University · Van · NCT07893925

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.